Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $50.83 Analyst target: $49.02 Upside: -3.56%
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
See the full interactive analysis & chart →Informational only — not investment advice.